- 询价
- Biovision
- A2156-100
- 2025年11月25日
企业认证
相关产品推荐更多 >
Mouse anti-S100A2 Monoclonal Antibody(1592CT417.84.81)【小鼠抗S100A2单克隆抗体(1592CT417.84.81)】
￥1500
Rabbit anti-PKC δ Monoclonal Antibody【兔抗PKCδ单克隆抗体】- abs156084
￥1800
Rabbit anti-GLIPR1 Polyclonal Antibody【兔抗GLIPR1多克隆抗体】- abs152664
￥1600
IF500 Rat anti-Human CD11b Antibody(M1/70)【IF500大鼠抗人CD11b抗体(M1/70)】- abs1850606
￥700PerCP-Cy5.5 Mouse anti-Human CD42b Antibody(HIP1)【PerCP-Cy5.5鼠抗人CD42b抗体(HIP1)】- abs1841098
￥1550
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
上海优宁维生物科技股份有限公司
- 规格：
100µg
| 产品货号 | 品牌 | 产品名称 | 规格 | 大包装及货期 |
| A2156-100 | Biovision | Anti-PD-1 (Sintilimab), Human IgG4 Antibody | 100µg | 立即咨询 |
| 更多产品信息请进入优宁维商城咨询 : |
优宁维，自2004年成立以来一直专注于抗体及相关产品，是国内专业全面的抗体供应商和抗体专家，并已努力发展成为生命科学一站式服务商。我们长期聚焦于生命科学、生物医药、医疗诊断、分析检测等领域，主要提供 包括抗体、重组蛋白、细胞因子、ELISA试剂盒、流式试剂、免疫组化试剂、生化试剂、分子生物学试剂、细胞系和细胞产品、科学仪器、耗材、LabEx（多因子检测服务）、产品订制服务、技术培训、软件和供应链等在内的生命科学一站式产品及服务，通过优宁维官网商城可下单超过 100万种商品和服务。  |
| 网址：www.univ-bio.com ｜电话：4008-168-068 |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Human IL-2 Enzyme Immunoassay (EIA)
2 antibodies for the capture of human IL-2 from specimens. An IL-2 standard is provided and is simultaneously processed with specimens. In order to detect the captured IL-2 a second anti-IL-2 antibody that has been biotinylated is added to all wells
Dual- and Triple-Color Fluorospot
a third detection antibody from a unique species that can be detected by fluorophore-labeled species-specific anti-Ig antibodies, reactive only with the third detection antibody (12). However, in a wider perspective, this may be a limiting factor since most highly
Preclinical Testing of Strategies for Therapeutic Targeting of Human T-Cell Trafficking In Vivo
effects. Therapeutic targeting of T-cell trafficking to the central nervous system is the underlying concept of a novel treatment of relapsing remitting multiple sclerosis with the humanized anti-α-4-integrin antibody natalizumab. In this chapter
技术资料暂无技术资料 索取技术资料
